This segment focuses on the production of traditional Chinese medicine (TCM) products, including pills, powders, wines, capsules, oral liquids, and dripping pills. Research and development efforts are directed towards optimizing formulations and manufacturing processes to ensure product quality and efficacy. The segment leverages traditional techniques combined with modern pharmaceutical technologies to produce a wide range of TCM products targeting cardiovascular, cerebrovascular, and gynecological diseases, as well as anti-depressive new drugs. The manufacturing segment adheres to strict quality control standards and regulatory requirements to ensure patient safety and product consistency. Future opportunities include expanding production capacity and developing innovative TCM formulations to meet evolving market demands.

The pharmaceutical retail segment is responsible for the distribution and sale of Beijing Tongrentang's TCM products through various channels, including company-owned stores, retail partnerships, and online platforms. This segment focuses on providing customers with access to high-quality TCM products and personalized healthcare advice. Research and development efforts are directed towards understanding customer needs and preferences to optimize product offerings and enhance the customer experience. The retail segment leverages digital technologies and e-commerce platforms to expand its reach and improve customer engagement. Future opportunities include expanding the retail network, developing innovative marketing strategies, and leveraging data analytics to personalize customer interactions and drive sales growth.